Prestige Consumer Healthcare cuts FY27 adjusted diluted EPS outlook to $4.48-$4.55
PBH•Prestige Consumer Healthcare lowered its fiscal 2027 revenue outlook to $1.28 billion-$1.29 billion and adjusted diluted EPS forecast to $4.48-$4.55. It now expects approximately flat organic revenue and adjusted free cash flow of at least $265 million.
1. FY27 outlook lowered
Prestige Consumer Healthcare cut its fiscal 2027 revenue guidance from $1.29 billion-$1.315 billion to $1.28 billion-$1.29 billion, and its adjusted diluted EPS forecast from $4.55-$4.65 to $4.48-$4.55. Adjusted free cash flow is projected at $265 million or more, compared with a previous minimum of $270 million.
2. Organic revenue expectations
The company expects organic revenue to be approximately flat, versus previous guidance for growth of 1%-3%. Excluding Clear Eyes, growth should approach 2%; lower second-half Clear Eyes revenue is anticipated versus a year earlier. The earnings outlook reflects reduced revenue expectations and higher interest expense.
